Evolving knowledge and therapy of inflammatory bowel disease

Nature Reviews. Drug Discovery
Joshua R Korzenik, D K Podolsky

Abstract

With recent advances in the understanding of its pathophysiology, inflammatory bowel disease has become a very active area for the development of novel therapeutic agents. New targets for biologics include cytokines involved in T-cell activation, with antibodies directed against IL-12 and interferon-gamma. Selective adhesion molecule blockade has produced promising, though mixed, results. Recombinant human granulocyte-macrophage colony-stimulating factor might be effective in active Crohn's disease, presumably through stimulation of intestinal innate immune responses. With increasing evidence for a crucial role for luminal flora in maintaining the health of the bowel, strategies to manipulate intestinal bacteria using probiotics and prebiotics are being actively investigated as well.

References

Jul 1, 1993·The Journal of Clinical Investigation·D K PodolskyM deBeaumont
Oct 1, 1996·Alimentary Pharmacology & Therapeutics·V Canva-DelcambreJ F Colombel
Apr 1, 1997·Digestive Diseases and Sciences·C FavierJ Mizon
Jun 1, 1997·Gut·J M Rhodes
Mar 13, 1998·Gastroenterology·S O Lopez-CuberoG B McDonald
Dec 3, 1998·Gastroenterology·A Darfeuille-MichaudJ F Colombel
Jun 23, 1999·Proceedings of the National Academy of Sciences of the United States of America·L LaghiC R Boland
Dec 23, 1999·Therapeutic Apheresis : Official Journal of the International Society for Apheresis and the Japanese Society for Apheresis·A KawamuraJ Meguro
Jun 1, 2000·The New England Journal of Medicine·A E SlonimM J McKinley
Aug 29, 2000·Digestive Diseases and Sciences·M GuslandiP A Testoni
Nov 23, 2000·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·G ChinettiB Staels
May 26, 2001·The American Journal of Gastroenterology·S VidelaJ R Malagelada
Dec 26, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·Stefan WirtzMarkus F Neurath
Apr 20, 2002·Science·Maria YazdanbakhshRonald van Ree
Jun 22, 2002·Gut·S J H van Deventer
Aug 9, 2002·The New England Journal of Medicine·Daniel K Podolsky
Oct 3, 2002·Gastroenterology·Michael JeffersHenri S Lichenstein

❮ Previous
Next ❯

Citations

Feb 20, 2007·Inflammatory Bowel Diseases·Giovanni LatellaRenzo Caprilli
Jul 20, 2007·Inflammatory Bowel Diseases·Laurent Peyrin-BirouletMathias Chamaillard
Jul 16, 2008·Inflammatory Bowel Diseases·Yasuhiro NemotoMamoru Watanabe
Sep 26, 2008·Inflammatory Bowel Diseases·Richard Blumberg
Aug 21, 2010·Inflammatory Bowel Diseases·Sa'ad Y Salim, Johan D Söderholm
Aug 5, 2010·Inflammatory Bowel Diseases·Jeroni LunaMiquel Sans
Nov 9, 2011·Immunology and Cell Biology·Charlotte E EganEric Y Denkers
Nov 4, 2011·The New England Journal of Medicine·Silvio Danese, Claudio Fiocchi
Oct 25, 2006·International Ophthalmology Clinics·Stephen C Pflugfelder
Jul 3, 2013·Inflammatory Bowel Diseases·Dmitry V Ostanin, Dhruva Bhattacharya
Jan 31, 2007·Arthritis Research & Therapy·Eveline TrachselDario Neri
Sep 30, 2010·Immunotherapy·Aiping Bai, Zhikang Peng
Mar 20, 2008·World Journal of Gastroenterology : WJG·Tsung-Chieh ShihCheng-Tang Chiu
Feb 26, 2011·World Journal of Gastroenterology : WJG·Guillaume BouguenLaurent Peyrin-Biroulet
Nov 29, 2013·Immunotherapy·Qingdong GuanZhikang Peng
May 15, 2013·Toxicology and Applied Pharmacology·Marwa M NagibAmani E Khalifa
Dec 1, 2008·Journal of Crohn's & Colitis·Florian Rieder, Claudio Fiocchi
Feb 27, 2009·Digestive Diseases and Sciences·Hirotsugu UeharaYasushi Saito
Aug 10, 2013·Free Radical Research·A MangerichG N Wogan
Sep 1, 2006·Expert Review of Clinical Immunology·Marcus Svensson, William W Agace
Jul 3, 2010·Expert Review of Clinical Immunology·Thomas T MacDonald
Jul 1, 2009·Expert Review of Clinical Pharmacology·Alfredo PapaAntonio Gasbarrini
Nov 27, 2009·Expert Opinion on Investigational Drugs·Luis Rodrigo
Apr 14, 2006·Expert Opinion on Biological Therapy·Takanori KanaiMamoru Watanabe
May 11, 2007·Expert Opinion on Drug Delivery·Mayank D Bhavsar, Mansoor M Amiji
Apr 22, 2014·Journal of Controlled Release : Official Journal of the Controlled Release Society·Amit SinghMansoor Amiji
Aug 25, 2012·Trends in Molecular Medicine·Mireille Alhouayek, Giulio G Muccioli
Jun 19, 2012·The Medical Clinics of North America·Jatinder P Ahluwalia
Nov 22, 2011·Pathologie-biologie·C SpenléP Simon-Assmann
Jul 8, 2008·Lancet·Laurent Peyrin-BirouletJean-Frédéric Colombel
May 18, 2011·International Immunopharmacology·Kazuhiro IshiguroHidemi Goto
Jun 15, 2007·The Surgical Clinics of North America·M Nedim Ince, David E Elliott

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adhesion Molecules in Health and Disease

Cell adhesion molecules are a subset of cell adhesion proteins located on the cell surface involved in binding with other cells or with the extracellular matrix in the process called cell adhesion. In essence, cell adhesion molecules help cells stick to each other and to their surroundings. Cell adhesion is a crucial component in maintaining tissue structure and function. Discover the latest research on adhesion molecule and their role in health and disease here.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Related Papers

Science
Thomas T MacDonald, Giovanni Monteleone
The New England Journal of Medicine
Jaime García de TenaMelchor Alvarez-Mon
Inflammatory Bowel Diseases
Raymond K Cross, Keith T Wilson
© 2021 Meta ULC. All rights reserved